We are live on ! Find out more
LDRS

Innovator IBD ETF Leaders ETF

Delisted

LDRS was delisted on the 13th of August, 2021.

3 hedge funds and large institutions have $950K invested in Innovator IBD ETF Leaders ETF in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 43 (-1)

47% less capital invested

Capital invested by funds: $1.78M → $950K (-$834K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$860K +$850K +30,912 New
Osaic Holdings
2
Osaic Holdings
Arizona
$67K
UBS Group
3
UBS Group
Switzerland
$23K -$46K -1,672 -67%
OMC
4
Old Mission Capital
Illinois
-$1.3M -48,440 Closed
LPL Financial
5
LPL Financial
California
-$356K -13,312 Closed

LDRS Hedge Fund Activity: Q2 2021 in Review

3 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q2 2021, worth a combined $950K — down 47% from $1.78M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of LDRS and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $850K. The largest seller was Old Mission Capital, exiting entirely with an estimated $1.3M sold.

  • 3 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q2 2021, down from 4 in Q1 2021.
  • Funds reported $950K of Innovator IBD ETF Leaders ETF stock for Q2 2021, down 47% quarter-over-quarter.
  • 1 fund opened new Innovator IBD ETF Leaders ETF positions in Q2 2021 and 2 closed out, a net change of -1 holder.
  • The largest Innovator IBD ETF Leaders ETF buyer in Q2 2021 was Susquehanna International Group, an estimated $850K added.
  • The largest Innovator IBD ETF Leaders ETF seller in Q2 2021 was Old Mission Capital, an estimated $1.3M sold.

Based on aggregated 13F filings for Q2 2021.